BXP insider plans sale of 1,194 shares

BXP, Inc. has a Form 144 notice covering the proposed sale of 1,194 shares of its common stock, par value $0.01, through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 76093.00.

Rhea-AI Filing Summary

BXP, Inc. has a Form 144 notice covering the proposed sale of 1,194 shares of its common stock, par value $0.01, through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 76093.00.

The shares come from grants of restricted stock from BXP, Inc., including 654 shares acquired on 01/28/2022 and 540 shares acquired on 02/03/2023. The notice lists an approximate sale date of 02/05/2026 and states that the filer represents having no undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for BXP disclose?

The Form 144 discloses a planned sale of 1,194 shares of BXP, Inc. common stock. These shares were granted as restricted stock in 2022 and 2023 and are expected to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

How many BXP shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 1,194 shares of BXP, Inc. common stock. The filing lists an aggregate market value of 76093.00 for these shares, indicating the scale of the intended transaction relative to the issuer’s overall equity.

When were the BXP shares in this Form 144 originally acquired?

The shares were acquired through restricted stock grants from BXP, Inc. on two dates. One grant covered 654 shares on 01/28/2022, and another covered 540 shares on 02/03/2023, both noted as grants from the issuer.

On which exchange will the BXP shares in this Form 144 be sold?

The Form 144 indicates the 1,194 BXP, Inc. common shares are intended to be sold on the NYSE. Morgan Stanley Smith Barney LLC is listed as the broker, with the approximate sale date shown as 02/05/2026 in the filing’s securities information section.

What representation does the seller make in the BXP Form 144?

The seller represents that they do not know any material adverse information about BXP, Inc. that has not been publicly disclosed. This representation is part of the signed notice and is required when filing to sell restricted or control securities under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/05/2026 - 03:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001900835
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BXP, Inc.
SEC File Number	001-13087
Address of Issuer	800 BOYLSTON STREET SUITE 1900 BOSTON MASSACHUSETTS 02199
Phone	6172363300
Name of Person for Whose Account the Securities are To Be Sold	Spann Hilary J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock, par value $0.01	Morgan Stanley Smith Barney LLC 1 New York Plaza New York NY 10004	1194	76093.00	158468685	02/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock, par value $0.01	01/28/2022	Grant of restricted stock from Issuer	BXP, Inc.			654	01/28/2022	N/A
Common Stock, par value $0.01	02/03/2023	Grant of restricted stock from Issuer	BXP, Inc.			540	02/03/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kelli A. DiLuglio as attorney-in-fact for Hilary J. Spann
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)